UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of
The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 27, 2023
National Instruments Corporation
(Exact name of registrant as specified in its charter)
Delaware
|
|
000-25426
|
|
74-1871327
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
11500 North Mopac Expressway
Austin, Texas 78759
(Address of principal executive offices, including zip code)
(512) 683-0100
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value
|
NATI
|
The Nasdaq Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act
of 1934 (§240.12b-2 of this chapter):
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
|
Results of Operations and Financial Condition
|
Attached hereto as Exhibit 99.1 and incorporated by reference herein is the text of the press release of National Instruments Corporation (“NI”), dated July
27, 2023, regarding the unaudited financial results for NI’s second fiscal quarter ended June 30, 2023.
The information in the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
On July 27, 2023, NI announced that its Board of Directors declared a dividend of $0.28 per share payable on August 29, 2023 to stockholders of record at the
close of business on August 8, 2023. A copy of the press release announcing the dividend is attached hereto as Exhibit 99.1.
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits.
Exhibit No.
|
|
Description
|
99.1
|
|
|
104
|
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
NATIONAL INSTRUMENTS CORPORATION
|
|
|
By:
|
/s/ R. Eddie Dixon, Jr.
|
|
|
Name: R. Eddie Dixon, Jr.
Title: Chief Legal Officer, Senior Vice President & Secretary
|
Date: July 27, 2023
NI Reports Record Revenue for a Second Quarter
Strong execution in challenging macro environment
Q2 2023 Summary
•
|
Record GAAP revenue for a second quarter of $417 million, up 5 percent year over year
|
•
|
Solid Q2 GAAP operating margin of 10%
|
•
|
Record Q2 Non-GAAP operating margin of 22%
|
•
|
Strong diluted GAAP EPS of $0.23 and diluted non-GAAP EPS of
$0.51
|
AUSTIN, Texas - July 27, 2023 - National
Instruments Corporation (Nasdaq: NATI) today announced Q2 2023 revenue of $417 million, up 5 percent year over year, a record for a second quarter.
In Q2, the total value of the company's orders was down 17 percent year over year. Orders were down 20 percent in the Americas, down 26 percent in APAC, and flat in EMEA year over year.
In Q2, GAAP gross margin was 72 percent and non-GAAP gross margin was 74 percent. Total GAAP operating expenses were $257 million and non-GAAP operating expenses were $218 million. GAAP operating income
for Q2 was $41 million with non-GAAP operating income of $91 million. In Q2, GAAP operating margin was 10 percent with non-GAAP operating margin of 22 percent.
In Q2, GAAP net income for Q2 was $30 million and non-GAAP net income was $68 million, with GAAP diluted EPS of $0.23 and non-GAAP diluted EPS of $0.51.
“I am pleased with our results in the second quarter. We delivered record revenue for a second quarter, along with strong operating margin and EPS, which
demonstrates the operating leverage we have developed through our ongoing transformation. Revenue was up 5 percent year-over-year and was bolstered
by our strong backlog, even as orders weakened more than we initially anticipated throughout the quarter,” said Eric Starkloff, NI President and CEO. “Despite the challenging macro environment, we executed our strategy. Our performance is a testament
to our continued focus on high growth subsegments and global execution.”
"Our focus on operational execution and expense management continued, resulting in second quarter GAAP operating margin up over 450 bps and non-GAAP operating
margin up over 600 bps as compared to the same quarter last year," said Daniel Berenbaum, NI CFO. "While we still see difficulty in obtaining reliable supply of a few specific parts, a general easing of supply chain constraints combined with the
laser-focus of our team enabled more shipments from our strong backlog, offsetting a difficult bookings environment."
As of June 30, 2023, NI had $139 million in cash and cash equivalents. During the second quarter, NI paid $37
million in dividends. The NI Board of Directors approved a quarterly dividend of $0.28 per share payable on August 29, 2023, to stockholders of record on August 8, 2023.
NI's non-GAAP results exclude, as applicable, the impact of purchase accounting fair value adjustments, stock-based compensation, amortization of
acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains
on buildings and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs. Reconciliations of the NI's GAAP and non-GAAP
results are included as part of this news release.
YTD 2023 Summary
•
|
Record GAAP revenue of $854 million, up 9 percent year over year
|
•
|
Strong GAAP operating margin of 11% and record non-GAAP operating margin of 23%
|
•
|
Strong diluted GAAP EPS of $0.58, up 107 percent year over
year and record diluted non-GAAP EPS of $1.13, up 47 percent year over year
|
Non-GAAP Presentation
To supplement NI’s financial statements presented on a GAAP basis, NI has provided non-GAAP financial information, including non-GAAP revenue or net sales,
gross profit, gross margin, operating expenses, operating income, operating margin, provision for income taxes, net income, net margin and diluted EPS. A reconciliation of the adjustments to GAAP results is included in the tables below. Non-GAAP
financial information is not meant as a substitute for GAAP results, but is included because management believes such information is useful to our investors for informational and comparative purposes. In addition, certain non-GAAP financial
information is used internally by management to evaluate and manage the company. The non-GAAP financial information used by NI may differ from that used by other companies. These non-GAAP measures should be considered in addition to, and not as a
substitute for, the results prepared in accordance with GAAP.
Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Exchange Act that are subject to risks and uncertainties. These statements include those set forth above relating to our ability to execute on our strategy. All forward-looking statements are based on current expectations and projections of future
events. We claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 for all forward-looking statements. Although we believe that the expectations reflected in the
forward-looking statements are reasonable, forward-looking statements are not guarantees of performance and actual results could differ materially from those projected in the forward-looking statements as a result of a number of important factors
which could affect our future results and could cause those results or other outcomes to differ materially from those expressed or implied in the forward-looking statements. Risks and uncertainties include without limitation: the global shortage of
key components; effect of the global economic and geopolitical conditions; our international operations and foreign economies; adverse public health matters, including epidemics and pandemics such as the COVID-19 pandemic; our ability to effectively
manage our partners and distribution channels; interruptions in our technology systems or cyber-attacks on our systems; the dependency of our product revenue on certain industries and the risk of contractions in such industries; concentration of
credit risk and uncertain conditions in the global financial markets; our ability to compete in markets that are highly competitive; our ability to release successful new products or achieve expected returns; the risk that our manufacturing capacity
and a substantial majority of our warehousing and distribution capacity are located outside of the U.S.; our dependence on key suppliers and distributors; longer delivery lead times from our suppliers; risk of product liability claims; dependence on
our proprietary rights and risks of intellectual property litigation; the continued service of key management, technical personnel and operational employees; our ability to comply with environmental laws and associated costs; our ability to maintain
our website; the risks of bugs, vulnerabilities, errors or design flaws in our products; our restructuring activities; our exposure to large orders; our shift to more system orders; our ability to effectively manage our operating expenses and meet
budget; fluctuations in our financial results due to factors outside of our control; our outstanding debt; the interest rate risk associated with our variable rate indebtedness; seasonal variation in our revenues; our ability to comply with laws and
regulations; changes in tax rates and exposure to additional tax liabilities; our ability to make certain acquisitions or dispositions, integrate the companies we acquire or separate the companies we sold and/or enter into strategic relationships;
risks related to currency fluctuations; provisions in charter documents and Delaware law that delay or prevent our acquisition; the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the proposed
transaction that could cause the parties to terminate the merger agreement entered into in connection with the proposed transaction; the occurrence of any event, change or other circumstances that could give rise to the termination of the merger
agreement; the risk that the parties to the merger agreement may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all; risks related to disruption of management time from ongoing business operations due to
the proposed transaction; the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of our common stock; the risk of any unexpected costs or expenses resulting from the proposed transaction;
the risk of any litigation relating to the proposed transaction; the risk that the proposed transaction and its announcement could have an adverse effect on the ability of the Company to retain customers and retain and hire key personnel and maintain
relationships with customers, suppliers, employees, stockholders and other business relationships and on its operating results and business generally; and the risk the pending proposed transaction could distract management of the Company. In
addition, our ability to declare and/or pay declared dividends is subject to compliance with the terms of our existing credit agreement. The Company directs readers to its Form 10-K for the year ended December 31, 2022 and the other documents it
files with the SEC for other risks associated with the Company’s future performance. These documents contain and identify important factors that could cause our actual results to differ materially from those contained in our forward-looking
statements. All information in this release is as of the date above. The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company’s expectations.
About NI
At NI, we bring together people, ideas and technology so forward thinkers and creative problem solvers can take on humanity’s biggest challenges. From data
and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day.
National Instruments, NI and ni.com and
Engineer Ambitiously are trademarks of National Instruments Corporation. Other product and company names listed are trademarks or trade names of their respective companies. (NATI-F)
National Instruments
|
|
Condensed Consolidated Balance Sheets
|
|
(in thousands)
|
|
|
|
June 30,
|
|
|
December 31,
|
|
|
|
2023
|
|
|
2022
|
|
|
|
(unaudited)
|
|
|
|
|
Assets
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
139,243
|
|
|
$
|
139,799
|
|
Accounts receivable, net
|
|
|
389,926
|
|
|
|
445,279
|
|
Inventories, net
|
|
|
401,626
|
|
|
|
388,164
|
|
Prepaid expenses and other current assets
|
|
|
123,949
|
|
|
|
115,677
|
|
Total current assets
|
|
|
1,054,744
|
|
|
|
1,088,919
|
|
Property and equipment, net
|
|
|
283,907
|
|
|
|
265,380
|
|
Goodwill
|
|
|
638,459
|
|
|
|
615,734
|
|
Intangible assets, net
|
|
|
192,904
|
|
|
|
200,850
|
|
Operating lease right-of-use assets
|
|
|
68,062
|
|
|
|
59,176
|
|
Other long-term assets
|
|
|
124,918
|
|
|
|
128,479
|
|
Total assets
|
|
$
|
2,362,994
|
|
|
$
|
2,358,538
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity
|
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses
|
|
$
|
60,514
|
|
|
$
|
54,639
|
|
Accrued compensation
|
|
|
49,575
|
|
|
|
71,422
|
|
Deferred revenue - current
|
|
|
158,247
|
|
|
|
137,208
|
|
Operating lease liabilities - current
|
|
|
16,608
|
|
|
|
13,834
|
|
Other taxes payable
|
|
|
55,622
|
|
|
|
67,615
|
|
Debt, current
|
|
|
25,000
|
|
|
|
25,000
|
|
Other current liabilities
|
|
|
58,833
|
|
|
|
153,157
|
|
Total current liabilities
|
|
|
424,399
|
|
|
|
522,875
|
|
Deferred income taxes
|
|
|
5,983
|
|
|
|
1,676
|
|
Income tax payable - non-current
|
|
|
22,581
|
|
|
|
40,646
|
|
Deferred revenue - non-current
|
|
|
60,094
|
|
|
|
63,066
|
|
Operating lease liabilities - non-current
|
|
|
36,486
|
|
|
|
30,588
|
|
Debt - non-current
|
|
|
564,373
|
|
|
|
516,637
|
|
Other long-term liabilities
|
|
|
31,558
|
|
|
|
26,926
|
|
Total liabilities
|
|
$
|
1,145,474
|
|
|
$
|
1,202,414
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
1,328
|
|
|
|
1,310
|
|
Additional paid-in capital
|
|
|
1,251,971
|
|
|
|
1,207,420
|
|
Retained earnings
|
|
|
(11,295
|
)
|
|
|
(14,741
|
)
|
Accumulated other comprehensive loss
|
|
|
(24,484
|
)
|
|
|
(37,865
|
)
|
Total stockholders' equity
|
|
|
1,217,520
|
|
|
|
1,156,124
|
|
Total liabilities and stockholders' equity
|
|
$
|
2,362,994
|
|
|
$
|
2,358,538
|
|
National Instruments
|
|
Condensed Consolidated Statements of Income
|
|
(in thousands, except per share data, unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2023
|
|
|
2022
|
|
|
2023
|
|
|
2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
Product
|
|
$
|
379,436
|
|
|
$
|
354,805
|
|
|
$
|
779,835
|
|
|
$
|
698,489
|
|
Software maintenance
|
|
|
37,368
|
|
|
|
40,710
|
|
|
|
73,794
|
|
|
|
82,281
|
|
Total net sales
|
|
|
416,804
|
|
|
|
395,515
|
|
|
|
853,629
|
|
|
|
780,770
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product
|
|
|
113,625
|
|
|
|
123,307
|
|
|
|
241,181
|
|
|
|
238,332
|
|
Software maintenance
|
|
|
4,862
|
|
|
|
4,167
|
|
|
|
10,012
|
|
|
|
8,370
|
|
Total cost of sales
|
|
|
118,487
|
|
|
|
127,474
|
|
|
|
251,193
|
|
|
|
246,702
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
298,317
|
|
|
|
268,041
|
|
|
|
602,436
|
|
|
|
534,068
|
|
|
|
|
71.6%
|
|
|
|
67.8%
|
|
|
|
70.6%
|
|
|
|
68.4%
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
123,101
|
|
|
|
124,908
|
|
|
|
240,443
|
|
|
|
245,064
|
|
Research and development
|
|
|
83,801
|
|
|
|
85,589
|
|
|
|
170,438
|
|
|
|
167,750
|
|
General and administrative
|
|
|
50,504
|
|
|
|
36,772
|
|
|
|
93,719
|
|
|
|
69,949
|
|
Total operating expenses
|
|
|
257,406
|
|
|
|
247,269
|
|
|
|
504,600
|
|
|
|
482,763
|
|
Operating income
|
|
|
40,911
|
|
|
|
20,772
|
|
|
|
97,836
|
|
|
|
51,305
|
|
Other expense
|
|
|
(8,500
|
)
|
|
|
(3,505
|
)
|
|
|
(11,519
|
)
|
|
|
(3,473
|
)
|
Income before income taxes
|
|
|
32,411
|
|
|
|
17,267
|
|
|
|
86,317
|
|
|
|
47,832
|
|
Provision for income taxes
|
|
|
1,919
|
|
|
|
4,833
|
|
|
|
8,896
|
|
|
|
10,162
|
|
Net income
|
|
$
|
30,492
|
|
|
$
|
12,434
|
|
|
$
|
77,421
|
|
|
$
|
37,670
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share
|
|
$
|
0.23
|
|
|
$
|
0.09
|
|
|
$
|
0.59
|
|
|
$
|
0.29
|
|
Diluted earnings per share
|
|
$
|
0.23
|
|
|
$
|
0.09
|
|
|
$
|
0.58
|
|
|
$
|
0.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
132,369
|
|
|
|
131,973
|
|
|
|
131,850
|
|
|
|
132,039
|
|
Diluted
|
|
|
134,171
|
|
|
|
132,708
|
|
|
|
133,693
|
|
|
|
132,948
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per share
|
|
$
|
0.28
|
|
|
$
|
0.28
|
|
|
$
|
0.56
|
|
|
$
|
0.56
|
|
|
|
Condensed Consolidated Statements of Cash Flows
|
|
(in thousands, unaudited)
|
|
|
|
Six Months Ended June 30,
|
|
|
|
2023
|
|
|
2022
|
|
|
|
|
|
Cash flow from operating activities:
|
|
|
|
|
|
|
Net income
|
|
$
|
77,421
|
|
|
$
|
37,670
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
45,541
|
|
|
|
45,742
|
|
Stock-based compensation
|
|
|
30,388
|
|
|
|
40,804
|
|
Loss from equity-method investees
|
|
|
(5,597
|
)
|
|
|
(131
|
)
|
Deferred income taxes
|
|
|
2,488
|
|
|
|
943
|
|
Net change in operating assets and liabilities
|
|
|
(75,368
|
)
|
|
|
(169,930
|
)
|
Net cash (used in) provided by operating activities
|
|
|
74,873
|
|
|
|
(44,902
|
)
|
|
|
|
|
|
|
|
|
|
Cash flow from investing activities:
|
|
|
|
|
|
|
|
|
Acquisitions, net of cash received
|
|
|
(23,024
|
)
|
|
|
(72,802
|
)
|
Capital expenditures
|
|
|
(35,477
|
)
|
|
|
(24,509
|
)
|
Capitalization of internally developed software
|
|
|
(925
|
)
|
|
|
(187
|
)
|
Additions to other intangibles
|
|
|
(3,811
|
)
|
|
|
(2,478
|
)
|
Net cash used in investing activities
|
|
|
(63,237
|
)
|
|
|
(99,976
|
)
|
|
|
|
|
|
|
|
|
|
Cash flow from financing activities:
|
|
|
|
|
|
|
|
|
Proceeds from revolving loan facility
|
|
|
120,000
|
|
|
|
175,000
|
|
Payments on revolving line of credit
|
|
|
(60,000
|
)
|
|
|
—
|
|
Proceeds from term loan
|
|
|
—
|
|
|
|
—
|
|
Payments on term loan
|
|
|
(12,500
|
)
|
|
|
—
|
|
Debt issuance costs
|
|
|
—
|
|
|
|
—
|
|
Proceeds from issuance of common stock
|
|
|
17,376
|
|
|
|
17,859
|
|
Repurchase of common stock
|
|
|
—
|
|
|
|
(70,000
|
)
|
Dividends paid
|
|
|
(73,975
|
)
|
|
|
(74,034
|
)
|
Other
|
|
|
(3,075
|
)
|
|
|
—
|
|
Net cash used in financing activities
|
|
|
(12,174
|
)
|
|
|
48,825
|
|
|
|
|
|
|
|
|
|
|
Impact of changes in exchange rates on cash
|
|
|
(18
|
)
|
|
|
(4,180
|
)
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
(556
|
)
|
|
|
(100,233
|
)
|
Cash and cash equivalents at beginning of period
|
|
|
139,799
|
|
|
|
211,106
|
|
Cash and cash equivalents at end of period
|
|
$
|
139,243
|
|
|
$
|
110,873
|
|
The following tables provide details with respect to the amount of GAAP charges related to stock-based compensation, amortization of acquisition-related
intangibles and fair value adjustments, acquisition-related transaction and integration costs, capitalization and amortization of internally developed software costs, restructuring charges, gains on sale of business/assets, and other that
were recorded in the line items indicated below (unaudited) (in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023
|
|
|
2022
|
|
|
2023
|
|
|
2022
|
|
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
$
|
467
|
|
|
$
|
1,253
|
|
|
$
|
1,429
|
|
|
$
|
2,475
|
|
Sales and marketing
|
|
|
5,792
|
|
|
|
7,202
|
|
|
|
10,727
|
|
|
|
14,291
|
|
Research and development
|
|
|
5,146
|
|
|
|
6,271
|
|
|
|
10,264
|
|
|
|
12,359
|
|
General and administrative
|
|
|
3,424
|
|
|
|
5,951
|
|
|
|
7,967
|
|
|
|
11,680
|
|
Provision for income taxes
|
|
|
(6,020
|
)
|
|
|
(1,993
|
)
|
|
|
(7,821
|
)
|
|
|
(4,648
|
)
|
Total
|
|
$
|
8,809
|
|
|
$
|
18,684
|
|
|
$
|
22,566
|
|
|
$
|
36,157
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of acquisition-related intangibles and fair value adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
—
|
|
|
$
|
371
|
|
|
$
|
—
|
|
|
$
|
742
|
|
Cost of sales
|
|
|
8,402
|
|
|
|
6,415
|
|
|
|
15,062
|
|
|
|
10,218
|
|
Sales and marketing
|
|
|
4,694
|
|
|
|
5,573
|
|
|
|
9,267
|
|
|
|
11,712
|
|
Research and development
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(320
|
)
|
Other (expense) income
|
|
|
320
|
|
|
|
503
|
|
|
|
753
|
|
|
|
1,019
|
|
Provision for income taxes
|
|
|
(2,014
|
)
|
|
|
(2,094
|
)
|
|
|
(3,505
|
)
|
|
|
(3,530
|
)
|
Total
|
|
$
|
11,402
|
|
|
$
|
10,768
|
|
|
$
|
21,577
|
|
|
$
|
19,841
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition transaction and integration costs, restructuring charges, and other(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
$
|
982
|
|
|
$
|
1,159
|
|
|
$
|
2,502
|
|
|
$
|
1,944
|
|
Sales and marketing
|
|
|
3,225
|
|
|
|
2,339
|
|
|
|
9,169
|
|
|
|
2,646
|
|
Research and development
|
|
|
497
|
|
|
|
487
|
|
|
|
3,735
|
|
|
|
1,102
|
|
General and administrative
|
|
|
16,555
|
|
|
|
1,248
|
|
|
|
24,492
|
|
|
|
3,019
|
|
Other (expense) income
|
|
|
48
|
|
|
|
(265
|
)
|
|
|
(2,449
|
)
|
|
|
(2,132
|
)
|
Provision for income taxes
|
|
|
(4,569
|
)
|
|
|
(779
|
)
|
|
|
(8,867
|
)
|
|
|
(1,356
|
)
|
Total
|
|
$
|
16,738
|
|
|
$
|
4,189
|
|
|
$
|
28,582
|
|
|
$
|
5,223
|
|
(1) Includes costs related to our announced merger with Emerson Electric Co. incurred during the first and second quarter of 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Capitalization) and amortization of internally developed software costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales
|
|
$
|
659
|
|
|
$
|
1,896
|
|
|
$
|
1,390
|
|
|
$
|
3,929
|
|
Research and development
|
|
|
—
|
|
|
|
—
|
|
|
|
(910
|
)
|
|
|
(187
|
)
|
Provision for income taxes
|
|
|
(153
|
)
|
|
|
(436
|
)
|
|
|
(132
|
)
|
|
|
(843
|
)
|
Total
|
|
$
|
506
|
|
|
$
|
1,460
|
|
|
$
|
348
|
|
|
$
|
2,899
|
|
National Instruments
|
|
Reconciliation of GAAP to Non-GAAP Measures
|
|
(in thousands, unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2023
|
|
|
2022
|
|
|
2023
|
|
|
2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Gross Profit to Non-GAAP Gross Profit
|
|
|
|
|
|
|
|
Gross profit, as reported
|
|
$
|
298,317
|
|
|
$
|
268,041
|
|
|
$
|
602,436
|
|
|
$
|
534,068
|
|
Stock-based compensation
|
|
|
467
|
|
|
|
1,253
|
|
|
|
1,429
|
|
|
|
2,475
|
|
Amortization of acquisition-related intangibles and fair value adjustments
|
|
|
8,402
|
|
|
|
6,786
|
|
|
|
15,062
|
|
|
|
10,960
|
|
Acquisition transaction and integration costs, restructuring charges and other
|
|
|
982
|
|
|
|
1,159
|
|
|
|
2,502
|
|
|
|
1,944
|
|
Amortization of internally developed software costs
|
|
|
659
|
|
|
|
1,896
|
|
|
|
1,390
|
|
|
|
3,929
|
|
Non-GAAP gross profit
|
|
$
|
308,827
|
|
|
$
|
279,135
|
|
|
$
|
622,819
|
|
|
$
|
553,376
|
|
Non-GAAP gross margin
|
|
|
74.1%
|
|
|
|
70.5%
|
|
|
|
73.0%
|
|
|
|
70.8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses
|
|
|
|
|
|
|
|
|
|
Operating expenses, as reported
|
|
$
|
257,406
|
|
|
$
|
247,269
|
|
|
$
|
504,600
|
|
|
$
|
482,763
|
|
Stock-based compensation
|
|
|
(14,362
|
)
|
|
|
(19,424
|
)
|
|
|
(28,958
|
)
|
|
|
(38,330
|
)
|
Amortization of acquisition-related intangibles and fair value adjustments
|
|
|
(4,694
|
)
|
|
|
(5,573
|
)
|
|
|
(9,267
|
)
|
|
|
(11,392
|
)
|
Acquisition transaction and integration costs, restructuring charges and other
|
|
|
(20,277
|
)
|
|
|
(4,074
|
)
|
|
|
(37,396
|
)
|
|
|
(6,767
|
)
|
Capitalization of internally developed software costs
|
|
|
—
|
|
|
|
—
|
|
|
|
910
|
|
|
|
187
|
|
Non-GAAP operating expenses
|
|
$
|
218,073
|
|
|
$
|
218,198
|
|
|
$
|
429,889
|
|
|
$
|
426,461
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Operating Income to Non-GAAP Operating Income
|
|
|
|
|
|
|
|
|
|
Operating income, as reported
|
|
$
|
40,911
|
|
|
$
|
20,772
|
|
|
$
|
97,836
|
|
|
$
|
51,305
|
|
Stock-based compensation
|
|
|
14,829
|
|
|
|
20,677
|
|
|
|
30,387
|
|
|
|
40,805
|
|
Amortization of acquisition-related intangibles and fair value adjustments
|
|
|
13,096
|
|
|
|
12,359
|
|
|
|
24,329
|
|
|
|
22,352
|
|
Acquisition transaction and integration costs, restructuring charges and other
|
|
|
21,259
|
|
|
|
5,233
|
|
|
|
39,898
|
|
|
|
8,711
|
|
Net amortization of internally developed software costs
|
|
|
659
|
|
|
|
1,896
|
|
|
|
480
|
|
|
|
3,742
|
|
Non-GAAP operating income
|
|
$
|
90,754
|
|
|
$
|
60,937
|
|
|
$
|
192,930
|
|
|
$
|
126,915
|
|
Non-GAAP operating margin
|
|
|
21.8%
|
|
|
|
15.4%
|
|
|
|
22.6%
|
|
|
|
16.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes(1)
|
|
|
|
|
|
|
|
|
|
Provision for income taxes, as reported
|
|
$
|
1,919
|
|
|
$
|
4,833
|
|
|
$
|
8,896
|
|
|
$
|
10,162
|
|
Stock-based compensation
|
|
|
6,020
|
|
|
|
1,993
|
|
|
|
7,821
|
|
|
|
4,648
|
|
Amortization of acquisition-related intangibles and fair value adjustments
|
|
|
2,014
|
|
|
|
2,094
|
|
|
|
3,505
|
|
|
|
3,530
|
|
Acquisition transaction and integration costs, restructuring charges and other
|
|
|
4,569
|
|
|
|
779
|
|
|
|
8,867
|
|
|
|
1,356
|
|
Net amortization of internally developed software costs
|
|
|
153
|
|
|
|
436
|
|
|
|
132
|
|
|
|
843
|
|
Non-GAAP provision for income taxes(1)
|
|
$
|
14,675
|
|
|
$
|
10,135
|
|
|
$
|
29,221
|
|
|
$
|
20,539
|
|
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and
considers the current and deferred tax impact of those adjustments.
|
|
Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS
|
|
(in thousands, except per share data, unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
2023
|
|
|
2022
|
|
|
2023
|
|
|
2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income, as reported
|
|
$
|
30,492
|
|
|
$
|
12,434
|
|
|
$
|
77,421
|
|
|
$
|
37,670
|
|
Adjustments to reconcile net income to non-GAAP net income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
14,829
|
|
|
|
20,677
|
|
|
|
30,387
|
|
|
|
40,805
|
|
Amortization of acquisition-related intangibles and fair value adjustments
|
|
|
13,416
|
|
|
|
12,862
|
|
|
|
25,082
|
|
|
|
23,371
|
|
Acquisition transaction and integration costs, restructuring charges and other
|
|
|
21,307
|
|
|
|
4,968
|
|
|
|
37,449
|
|
|
|
6,579
|
|
Net amortization of internally developed software costs
|
|
|
659
|
|
|
|
1,896
|
|
|
|
480
|
|
|
|
3,742
|
|
Income tax effects and adjustments(1)
|
|
|
(12,756
|
)
|
|
|
(5,302
|
)
|
|
|
(20,325
|
)
|
|
|
(10,377
|
)
|
Non-GAAP net income
|
|
$
|
67,947
|
|
|
$
|
47,535
|
|
|
$
|
150,494
|
|
|
$
|
101,790
|
|
Non-GAAP net margin
|
|
|
16.3%
|
|
|
|
12.0%
|
|
|
|
17.6%
|
|
|
|
13.0%
|
|
|
|
Diluted EPS, as reported
|
|
$
|
0.23
|
|
|
$
|
0.09
|
|
|
$
|
0.58
|
|
|
$
|
0.28
|
|
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
0.11
|
|
|
|
0.16
|
|
|
|
0.23
|
|
|
|
0.31
|
|
Amortization of acquisition-related intangibles and fair value adjustments
|
|
|
0.10
|
|
|
|
0.10
|
|
|
|
0.19
|
|
|
|
0.18
|
|
Acquisition transaction and integration costs, restructuring charges and other
|
|
|
0.16
|
|
|
|
0.04
|
|
|
|
0.28
|
|
|
|
0.05
|
|
Net amortization of internally developed software costs
|
|
|
0.01
|
|
|
|
0.01
|
|
|
|
—
|
|
|
|
0.03
|
|
Income tax effects and adjustments(1)
|
|
|
(0.10
|
)
|
|
|
(0.04
|
)
|
|
|
(0.15
|
)
|
|
|
(0.08
|
)
|
Non-GAAP diluted EPS
|
|
$
|
0.51
|
|
|
$
|
0.36
|
|
|
$
|
1.13
|
|
|
$
|
0.77
|
|
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and
considers the current and deferred tax impact of those adjustments.
|
|
Weighted average shares outstanding - Diluted
|
|
|
134,171
|
|
|
|
132,708
|
|
|
|
133,693
|
|
|
|
132,948
|
|